Active ingredientPretomanidCat. No. P-P184-001CAS 187235-37-6Family · Pharmaceutical analytical standards
Pretomanid
An anti-tuberculosis drug of the nitroimidazole class, known during development as PA-824, approved in the United States in 2019 for highly drug-resistant pulmonary tuberculosis, together with bedaquiline and linezolid. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It was chosen in 2000 from a series of about 100 nitroimidazole derivatives: it was not the most potent in the test tube, but it was the most active in infected mice when given by mouth.
Go to the active ingredient →Active ingredientPretomanidCat. No. P-P184-001CAS 187235-37-6
Isotopically labelledPretomanid-d4Cat. No. P-P184-002CAS 1346617-34-2
ImpurityPretomanid 3-Nitro IsomerCat. No. P-P184-003CAS 1131004-99-3
ImpurityPretomanid Impurity 1Cat. No. P-P184-004
ImpurityPretomanid Impurity 2Cat. No. P-P184-005CAS 2222639-62-3
ImpurityPretomanid Impurity 3Cat. No. P-P184-006
ImpurityPretomanid Impurity 4Cat. No. P-P184-007
ImpurityPretomanid Meta Isomer ImpurityCat. No. P-P184-008CAS 1353753-57-7
ImpurityPretomanid Methoxy ImpurityCat. No. P-P184-009CAS 2512206-85-6
ImpurityPretomanid Ortho Isomer ImpurityCat. No. P-P184-010CAS 1353753-55-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.